Calviri, Inc Announces Formation of Scientific Advisory Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Calviri, Inc Announces Formation of Scientific Advisory Board
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Acg Advocacy: Newsguard Technologies
Alexander, Borovicka & O Shea Government Solutions (Fka Alexander & Borovicka Go: Volan Technology Inc.
Alpine Group Partners, LLC.: Enviva Holdings, Lp
Alpine Group Partners, LLC.: Takeda Pharmaceuticals America, Inc.
Alston & Bird LLP: USagainstalzheimers Action
Arent Fox LLP: Grand Street Settlement, Inc.
Bracewell LLP: Sustainable Opportunities Acquisition Corporation
Bramer Group, LLC: Ducommun Inc.
Capitol Counsel LLC: American Association Of Settlement Consultants
Capitol Counsel LLC: Rebuild Local News Coalition
Capitol Counsel LLC: United Spinal Association
Cavarocchi Ruscio Dennis Associates, L.L.C.: Cure Epilepsy
G2G Consulting: Lead Safe Cleveland Coalition
Grayrobinson Pa: City Of Apopka Fl
Hogan Lovells US LLP: Prodigy Education
Share this article
Share this article
HOUSTON, May 25, 2021 /PRNewswire/ AuraVax Therapeutics, Inc. (Auravax), a biotech company developing novel intranasal therapeutics and vaccines to help patients defeat debilitating respiratory diseases, including COVID-19, today announced the formation of its inaugural Scientific Advisory Board (SAB), consisting of leading experts in the fields of biology, vaccines and intranasal drug delivery. The SAB will guide and advise the company in its ongoing development of proprietary therapeutics and vaccines for respiratory diseases.
The SAB is chaired by George M. Church, Ph.D. and includes Stephen Albert Johnston from Calviri, Inc and Mei X. Wu, Ph.D. from Massachusetts General Hospital/Harvard Medical School.